BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21094827)

  • 1. Does model for end-stage liver disease score predict the short-term outcome of living donor liver transplantation?
    Li C; Wen T; Yan L; Li B; Wang W; Xu M; Yang J; Wei Y
    Transplant Proc; 2010 Nov; 42(9):3620-3. PubMed ID: 21094827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.
    Suzuki H; Bartlett AS; Muiesan P; Jassem W; Rela M; Heaton N
    Transplant Proc; 2012 Mar; 44(2):384-8. PubMed ID: 22410023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
    Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
    Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pre-liver transplantation renal insufficiency using a creatinine clearance calculator predict long-term survival?
    Boin IF; de Ataide EC; Dias EP; Stucchi RS; Seva-Pereira T; Calomeni G; Capel Junior CC; Mazzali M
    Transplant Proc; 2012 Oct; 44(8):2452-4. PubMed ID: 23026618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
    Dulundu E; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
    Hepatogastroenterology; 2006; 53(71):781-2. PubMed ID: 17086888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience.
    Grosso G; di Francesco F; Vizzini G; Mistretta A; Pagano D; Echeverri GJ; Spada M; Basile F; Gridelli B; Gruttadauria S
    Transplant Proc; 2012 Jun; 44(5):1298-302. PubMed ID: 22664004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience.
    Gruttadauria S; Vizzini G; Biondo D; Mandalà L; Volpes R; Palazzo U; Gridelli B
    Liver Transpl; 2008 Feb; 14(2):220-7. PubMed ID: 18236398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.